Trial NCT05687110

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2022-06608
Secondary IDs: 10528 NCI-2022-06608 UM1CA186709

Last trial update was posted on 2023-12-18

MeSH Interventions

Novobiocin

MeSH Conditions

Neoplasms

Other Conditions

Metastatic Malignant Solid Neoplasm Unresectable Malignant Solid Neoplasm

Stopping Reasons

Other - FDA Clinical Hold

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID